The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zinnat 125 mg/5 ml granules for oral suspension

Sandoz Pharmaceuticals d.d.PA23311/003/005

Main Information

Trade NameZinnat 125 mg/5 ml granules for oral suspension
Active SubstancesCefuroxime axetil
Dosage FormGranules for oral suspension
Licence HolderSandoz Pharmaceuticals d.d.
Licence NumberPA23311/003/005

Group Information

ATC CodeJ01DC Second-generation cephalosporins
J01DC02 cefuroxime


License statusAuthorised
Licence Issued16/01/1991
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back